CoChat
Sign Up
Cited by 141Hormonal and reproductive studiesAdrenal Hormones and DisordersMenopause: Health Impacts and Treatments

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Low Dehydroepiandrosterone and Ischemic Heart Disease in Middle-aged Men: Prospective Results from the Massachusetts Male Aging Study

Feldman, Henry A., Johannes, Catherine B., Araujo, Andre B., Mohr, Beth A., Longcope, Christopher, McKinlay, John B.·2001·American Journal of Epidemiology
DOI 10.1093/aje/153.1.79
Open this paper in CoChat — free account

Abstract

The adrenal steroid dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) have been characterized as "protective" against ischemic heart disease (IHD), especially in men, on the basis of sparse epidemiologic evidence. The authors used data from the Massachusetts Male Aging Study, a random sample prospective study of 1,709 men aged 40-70 years at baseline, to test whether serum levels of DHEA or DHEAS could predict incident IHD over a 9-year interval. At baseline (1987-1989) and follow-up (1995-1997), an interviewer-phlebotomist visited each subject in his home to obtain comprehensive health information, body measurements, and blood samples for hormone and lipid analysis. Incident IHD between baseline and follow-up was ascertained from hospital records and death registries, supplemented by self-report and evidence of medication. In the analysis sample of 1,167 men, those with serum DHEAS in the lowest quartile at baseline (<1.6 microg/ml) were significantly more likely to incur IHD by follow-up (adjusted odds ratio = 1.60, 95 percent confidence interval: 1.07, 2.39; p = 0.02), independently of a comprehensive set of known risk factors including age, obesity, diabetes, hypertension, smoking, serum lipids, alcohol intake, and physical activity. Low serum DHEA was similarly predictive. These results confirm prior evidence that low DHEA and DHEAS can predict IHD in men.

Overview

Integrity signals

Registry

Crossref · 10.1093/aje/153.1.79

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. Thijssen JHH, Nieuwenhuyse H, eds. DHEA: a comprehensive review. Pearl River, NY: Parthenon, 1999.
  2. Schaefer C, Friedman G, Ettinger B, et al. Dehydroepiandros-terone sulfate (DHEAS), angina, and fatal ischemic heart disease. (Abstract). Am J Epidemiol 1996;143:369.
  3. McKinlay JB, Feldman HA. Age-related variation in sexual activity and interest in normal men: results from the Massachusetts Male Aging Study. In: Rossi AS, ed. Sexuality across the life course: proceedings of the MacArthur Foundation Research Network on Successful Mid-Life Development, 1992. New York, NY: University of Chicago Press, 1994:261–85.
  4. Rosenthal R, Rosnow RL. Contrast analysis. Cambridge, UK: Cambridge University Press, 1985.

Cited by

Sorted by citations

See all 141

Related

See all

Metadata

Authors
Feldman, H. A., Johannes, C. B., Araujo, A. B., Mohr, B. A., Longcope, C., & McKinlay, J. B.
Affiliations
New England Research Institutes (US)
ORCID
Venue
American Journal of Epidemiology
Publisher
Oxford University Press (OUP)
Published
2001-01-01
Volume
153
Issue
1
Pages
79-89
ISSN
  • 0002-9262 (ISSN-L)
  • 1476-6256
DOI
10.1093/aje/153.1.79
OpenAlex
W2051423109
Cited by
141
References
76
Citations by year
2025: 3 · 2024: 5 · 2023: 3 · 2022: 5 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 4 · 2015: 5 · 2014: 11 · 2013: 4 · 2012: 5
FWCI
7.12
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Epidemiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r03hl050482-02, 7p01ag004673-05)
  • National Institute on Aging (AG 04673)
  • National Heart, Lung, and Blood Institute (HL-50482)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK044995, DK44995)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
dehydroepiandrosterone, dehydroepiandrosterone sulfate, ischemic heart disease, middle-aged men, serum steroid levels, cardiovascular risk prediction, Massachusetts Male Aging Study
MeSH terms
Adult, Aged, Aging, Dehydroepiandrosterone, Humans, Male, Massachusetts, Middle Aged, Predictive Value of Tests, Prospective Studies, Risk Factors, Cohort Studies, Incidence, Myocardial Ischemia, Dehydroepiandrosterone Sulfate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review